BioN­Tech ex­pands ADC deal with Du­al­i­ty­Bio; Gra­cell and IO Biotech get pri­vate place­ments from a slew of in­vestors

BioN­Tech is forg­ing a big­ger al­liance with its an­ti­body-drug con­ju­gate part­ner Du­al­i­ty­Bio, adding an­oth­er ADC to their bil­lion-dol­lar union.

Du­al­i­ty­Bio

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER